Shenzhen Hepalink Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Shenzhen Hepalink Pharmaceutical Co Ltd cash flow reinvestment rate. Shenzhen Hepalink Pharmaceutical Co Ltd (002399) has a Cash Flow Reinvestment Rate of 0.03x as of September 2025, reinvesting CN¥13.60 Million (capex CN¥13.60 Million ) from operating cash flow of CN¥399.43 Million. Explore 002399 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Shenzhen Hepalink Pharmaceutical Co Ltd (2006–2025)
Cash flow reinvestment rate of Shenzhen Hepalink Pharmaceutical Co Ltd from 2006 to 2025. Historical reinvestment intensity for Shenzhen Hepalink Pharmaceutical Co Ltd across 16 annual periods. Explore 002399 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Shenzhen Hepalink Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2006–2025)
Shenzhen Hepalink Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2006 to 2025. Year-by-year capital reinvestment analysis for Shenzhen Hepalink Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 002399 cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.45x | CN¥763.43 Million | CN¥1.71 Billion | CN¥121.10 Million | ▲ +287.0% |
| 2024 | 0.12x | CN¥252.68 Million | CN¥2.19 Billion | CN¥202.77 Million | ▼ -97.2% |
| 2023 | 4.18x | CN¥1.67 Billion | CN¥398.22 Million | CN¥444.88 Million | ▼ -93.1% |
| 2020 | 60.36x | CN¥2.25 Billion | CN¥37.28 Million | CN¥212.49 Million | ▲ +1329.2% |
| 2018 | 4.22x | CN¥2.82 Billion | CN¥667.87 Million | CN¥535.01 Million | ▲ +131.1% |
| 2016 | 1.83x | CN¥632.55 Million | CN¥346.07 Million | CN¥359.54 Million | ▲ +867.4% |
| 2015 | 0.19x | CN¥168.85 Million | CN¥893.71 Million | CN¥168.85 Million | ▲ +2.9% |
| 2014 | 0.18x | CN¥167.62 Million | CN¥912.80 Million | CN¥167.62 Million | ▼ -73.7% |
| 2013 | 0.70x | CN¥293.98 Million | CN¥420.97 Million | CN¥293.98 Million | ▲ +39.3% |
| 2012 | 0.50x | CN¥237.55 Million | CN¥473.89 Million | CN¥237.55 Million | ▲ +425.0% |
| 2011 | 0.10x | CN¥134.16 Million | CN¥1.41 Billion | CN¥134.16 Million | ▼ -5.7% |
| 2010 | 0.10x | CN¥35.93 Million | CN¥354.86 Million | CN¥35.93 Million | ▼ -34.4% |
| 2009 | 0.15x | CN¥54.91 Million | CN¥355.81 Million | CN¥54.91 Million | ▼ -42.7% |
| 2008 | 0.27x | CN¥10.81 Million | CN¥40.13 Million | CN¥10.81 Million | ▼ -68.8% |
| 2007 | 0.86x | CN¥11.95 Million | CN¥13.85 Million | CN¥11.95 Million | ▲ +477.7% |
| 2006 | 0.15x | CN¥10.71 Million | CN¥71.66 Million | CN¥10.71 Million | — |